309 related articles for article (PubMed ID: 17176063)
1. Matrix metalloproteinase-1 takes advantage of the induced fit mechanism to cleave the triple-helical type I collagen molecule.
O'Farrell TJ; Guo R; Hasegawa H; Pourmotabbed T
Biochemistry; 2006 Dec; 45(51):15411-8. PubMed ID: 17176063
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
Minond D; Lauer-Fields JL; Nagase H; Fields GB
Biochemistry; 2004 Sep; 43(36):11474-81. PubMed ID: 15350133
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the mechanisms by which gelatinase A, neutrophil collagenase, and membrane-type metalloproteinase MMP-14 recognize collagen I and enzymatically process the two alpha-chains.
Gioia M; Monaco S; Fasciglione GF; Coletti A; Modesti A; Marini S; Coletta M
J Mol Biol; 2007 May; 368(4):1101-13. PubMed ID: 17379243
[TBL] [Abstract][Full Text] [Related]
4. The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B.
O'Farrell TJ; Pourmotabbed T
Arch Biochem Biophys; 1998 Jun; 354(1):24-30. PubMed ID: 9633594
[TBL] [Abstract][Full Text] [Related]
5. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.
Mitchell PG; Magna HA; Reeves LM; Lopresti-Morrow LL; Yocum SA; Rosner PJ; Geoghegan KF; Hambor JE
J Clin Invest; 1996 Feb; 97(3):761-8. PubMed ID: 8609233
[TBL] [Abstract][Full Text] [Related]
6. Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides.
Xu X; Wang Y; Lauer-Fields JL; Fields GB; Steffensen B
Matrix Biol; 2004 Jun; 23(3):171-81. PubMed ID: 15296945
[TBL] [Abstract][Full Text] [Related]
7. Triple-helical peptide analysis of collagenolytic protease activity.
Lauer-Fields JL; Fields GB
Biol Chem; 2002; 383(7-8):1095-105. PubMed ID: 12437092
[TBL] [Abstract][Full Text] [Related]
8. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and collagen catabolism.
Lauer-Fields JL; Juska D; Fields GB
Biopolymers; 2002; 66(1):19-32. PubMed ID: 12228918
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
11. Unexpected crucial role of residue 272 in substrate specificity of fibroblast collagenase.
Tsukada H; Pourmotabbed T
J Biol Chem; 2002 Jul; 277(30):27378-84. PubMed ID: 12011042
[TBL] [Abstract][Full Text] [Related]
12. Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
Lauer-Fields JL; Broder T; Sritharan T; Chung L; Nagase H; Fields GB
Biochemistry; 2001 May; 40(19):5795-803. PubMed ID: 11341845
[TBL] [Abstract][Full Text] [Related]
13. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
14. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme.
Smith GN; Mickler EA; Hasty KA; Brandt KD
Arthritis Rheum; 1999 Jun; 42(6):1140-6. PubMed ID: 10366106
[TBL] [Abstract][Full Text] [Related]
15. Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses.
Syggelos SA; Eleftheriou SC; Giannopoulou E; Panagiotopoulos E; Aletras AJ
J Rheumatol; 2001 Jun; 28(6):1319-29. PubMed ID: 11409126
[TBL] [Abstract][Full Text] [Related]
16. Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity.
Chung L; Shimokawa K; Dinakarpandian D; Grams F; Fields GB; Nagase H
J Biol Chem; 2000 Sep; 275(38):29610-7. PubMed ID: 10871619
[TBL] [Abstract][Full Text] [Related]
17. The collagenolytic action of MMP-1 is regulated by the interaction between the catalytic domain and the hinge region.
Fasciglione GF; Gioia M; Tsukada H; Liang J; Iundusi R; Tarantino U; Coletta M; Pourmotabbed T; Marini S
J Biol Inorg Chem; 2012 Apr; 17(4):663-72. PubMed ID: 22407541
[TBL] [Abstract][Full Text] [Related]
18. Pivotal molecular determinants of peptidic and collagen triple helicase activities reside in the S3' subsite of matrix metalloproteinase 8 (MMP-8): the role of hydrogen bonding potential of ASN188 and TYR189 and the connecting cis bond.
Pelman GR; Morrison CJ; Overall CM
J Biol Chem; 2005 Jan; 280(3):2370-7. PubMed ID: 15533938
[TBL] [Abstract][Full Text] [Related]
19. Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
Chung L; Dinakarpandian D; Yoshida N; Lauer-Fields JL; Fields GB; Visse R; Nagase H
EMBO J; 2004 Aug; 23(15):3020-30. PubMed ID: 15257288
[TBL] [Abstract][Full Text] [Related]
20. Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B.
O'Farrell TJ; Pourmotabbed T
J Biol Chem; 2000 Sep; 275(36):27964-72. PubMed ID: 10823838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
